BRAINTREE, Mass., Nov. 17, 2010 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today the hire of Warren Nighan as Vice President of Worldwide Quality & Regulatory Affairs, who will join the Company’s Executive Council.
Mr. Nighan, age 41, most recently served as Vice President Quality & Regulatory for St. Jude Medical in Minneapolis, Minnesota. Prior to that, he held numerous roles of increasing responsibility in quality and regulatory affairs, at Covidien, Tyco Medical and Kendall Healthcare.
Mr. Nighan holds a bachelors degree in nursing from Northeastern University.
Brian Concannon, Haemonetics’ President and CEO said, “It is a great compliment to Haemonetics to have attracted a quality and regulatory executive of Warren’s stature and experience. Our company’s dedication to a culture of quality and compliance is closely aligned with our vision to be the global provider of blood management solutions for our customers who meet the daily transfusion needs of millions of patients around the world. We all welcome Warren back to New England.”
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
CONTACT: | |
Bryanne Salmon | |
Tel. (781) 356-9613 | |
SOURCE Haemonetics Corporation
